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Abstract Cytopathological examination through biopsy
is very important for carcinoma detection. The embedded
relay lens microscopic hyperspectral imaging system
(ERL-MHIS) provides a morphological image of a biopsy
sample and the spectrum of each pixel in the image
simultaneously. Based on the ERL-MHIS, this work
develops morphological and spectral methods to diagnose
oral carcinoma biopsy. In morphological discrimination,
the fractal dimension method is applied to differentiate
between normal and abnormal tissues. In spectral identifi-
cation, normal and cancerous cells are distinguished using
five methods. However, the spectra of normal and
cancerous cells vary with patient. The diagnostic perfor-
mances of the five methods are thus not ideal. Hence, the
proposed cocktail approach is used to determine the
effectiveness of the spectral methods in correlating with the
sampling conditions. And then we use a combination of
effective spectral methods according to the sample condi-
tions for diagnosing a sample. A total of 68 biopsies from
34 patients are analyzed using the ERL-MHIS. The results
demonstrate a sensitivity of 90 ± 4.53 % and a specificity
of 87.8 ± 5.21 %. Furthermore, in our survey, this system
is the first time utilized to study oral carcinoma biopsies.
Keywords Oral carcinoma  Hyperspectral imaging 
Biopsy  Microscopy
1 Introduction
Oral carcinoma is an important global health problem, as
evidenced by approximately 40,250 new cases of oral and
throat carcinoma detected in 2012 (American Cancer Soci-
ety). In theUnitedStates, the overall 5-year survival rate for all
stages of oral carcinoma is 61 % [1, 2]. Biopsy is the con-
ventional means of diagnosing oral carcinoma [3, 4]. In
addition to allowing pathologists to diagnose the stage of
carcinomaaccurately, biopsy also allows them toprescribe the
most appropriate treatment. However, differences in experi-
ence and subjectivity when evaluating borderline dysplastic
cells between pathologists might affect their diagnostic
accuracy. A microscopic hyperspectral imaging system
(MHIS) capable of presenting a tissue image and the spectral
information of each pixel in the image simultaneously was
developed to facilitate carcinoma diagnosis quantitatively [5–
16]. However, both the hardware and analytical algorithm
aspects of the conventional MHIS required further improve-
ment. Regarding hardware, the conventionalMHISwas time-
consuming, had a complex mechanical structure, high off-
axial optical aberration, and inconvenient alignment. The
embedded relay lensMHIS (ERL-MHIS, Fig. 1) developed in
our previous works overcomes these limitations [17, 18].
Certain limitations of analytical algorithms have pre-
ventedwidespreadMHIS application in carcinomadiagnosis
[11–15]. Siddiqi et al. [13] distinguished between normal
and cancerous cells by using the nuclear spectrum and then
further distinguished them based on the nuclear/cytoplasmic
ratio. Other works [11, 12, 14, 15] demonstrated that the
nuclear spectrum can present quantitative differences
between normal, precancerous, and cancer cells. However,
there are several problems with these studies. First, these
works used biopsies from only one patient. Although a
40 9 objective was used to examine every single cell in the
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biopsy, their conclusions may not be applicable to all cancer
patients. Second, the examination of every single cell in the
biopsy was quite time-consuming. Third, most pathologists
use a 20 9 objective [19]. Accordingly, the use of a high-
power objective (higher than 409) is inconvenient for
pathologists. Fourth, in a previous work, the sensitivity,
specificity, or both of discrimination between normal and
precancerous cells was about 70–80 % [13].
This work develops morphological and spectral methods
anduses them tohelppathologists quantitativelydiagnoseoral
carcinoma biopsy. The proposed methods were used to
diagnose68oral carcinomabiopsies of 34patients usingERL-
MHIS (with a 20 9 objective). In the spatial domain,
although the fractal dimension algorithm [20] can distinguish
between the morphological differences of normal and
abnormal tissues, an abnormal tissue does not represent a
cancerous tissue. Hence, normal and cancerous cells in the
tissue are distinguished in the spectral domain using five
methods. However, the spectra of normal and cancerous cells
vary with patient due to differences in sampling conditions
(e.g., age of patients, lesion site, tumor size, and lymph node
metastasis) [15, 21, 22]. Therefore, thiswork develops a novel
cocktail approach to reduce the difference in the cell spectrum
between patients. The proposed cocktail approach determines
the effectiveness of spectral methods in correlating with the
sampling conditions. The sample is then diagnosed using the
optimal combination of effective spectral methods.
2 Materials and Methods
2.1 ERL-MHIS
Figure 1(a) illustrates the functions and setup of the ERL-
MHIS. The designed relay lens for scanning is placed
between the microscope and the hyperspectrometer. The
stepping motor is located under the relay lens. The relay
lens comprises symmetric infinite conjugate lenses for
scanning and transferring images with optimal off-axis
optical aberration. The object on the platform is imaged
with the objective lens on imaging plane 1. The relay lens
then transfers the image from imaging plane 1 to imaging
plane 2, where the hyperspectrometer slit is located. The
slit is along the y axis direction. Imaging plane 2 images
one line (slit size) at a time on the electron-multiplying
charged-coupled device (EMCCD). When the relay lens is
static, the line image of slit size and the spectrum can be
recorded on the EMCCD. While the stepping motor moves
along the x-axis, the individual line images are recorded on
the y–k plane of the EMCCD. The stepping motor moves
one step in the x-axis direction to capture the next line
image and its spectrum. Each y–k image is recorded as a
single y–k file for each row along the object corresponding
to the radiation collection region, which maps through the
hyperspectrometer to the EMCCD. After all of the line
images are captured, the data cube of all of the y–k files are
loaded into memory.
The ERL-MHIS provides transmission and fluorescence
images of the biopsy to assist pathologists in detecting
cancerous cells or tissues. The transmission light source is
a 100-W halogen lamp. The fluorescent light source is a
75-W xenon lamp. The transmission image provides mor-
phological information and spectral information from 400
to 1000 nm of the cell or tissue. The fluorescence image
provides the characteristic spectrum of the cell or tissue.
The proposed system has two fluorescence modes (F1:
330–385 nm; F2: 470–490 nm). The fluorescence mode
can be changed by tuning the fluorescent wheel. Fig-
ure 1(b) shows the finished product of the proposed ERL-
MHIS, which consists of an inverted microscope (Olympus
Fig. 1 a Diagram and b photograph of ERL-MHIS (RL relay lens, HS hyperspectrometer, SM stepping motor, IMP1 imaging plane 1, IMP2
imaging plane 2, FW fluorescent wheel
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IX71), charged-coupled device (CCD; AVT PIKE F-421-
C), RL, stepping motor (Sigma Koki, SGSP20-20),
hyperspectrometer (Specim V10E, with spectral range of
400 to 1000 nm), and EMCCD (Andor Luca R604, with
1000 9 1000 pixels and 8-lm pixel size). The spatial
resolution of the ERL-MHIS is 30 lm 9 10 lm. The
objective power affects the spatial resolution. This
work uses a 20 9 objective (spatial resolution: 1.5 lm 9
0.5 lm). The spectral resolution of the ERL-MHIS is about
2.8 nm. The software for acquiring images and analyzing
spectral information was programmed in the C language.
The software controls the speed of the stepping motor,
gain, and exposure time of the EMCCD.
2.2 Patient Biopsy Preparations
Sixty eight biopsies of 34 oral carcinoma patients were
provided by the China Medical University Hospital (Tai-
Chung City, Taiwan). The 68 biopsies were divided into 58
training cases and 10 test cases. The type of test biopsy
(normal or cancerous) was not revealed to the analyst who
analyzed the 10 biopsies. The 58 training cases were uti-
lized to determine the most effective methods for each
sampling condition and its cut-off point. The performance
of the proposed approach was validated using the 10 test
cases.
Before the experiment, institutional review board (IRB)
approval was obtained from China Medical University
Hospital (IRB number DMR98-IRB-209). All patients
received complete information on this experiment before
providing their signed informed consent. This study was
implemented in accordance with the Declaration of
Helsinki.
The routine pathological diagnosis procedure with
hematoxylin and eosin (H&E) staining was utilized to
prepare the biopsies. After surgical operations, the oral
carcinoma and normal samples were resected from the
patients. Samples were then stained with H&E. Next, two
biopsies (normal and cancerous) were prepared from each
patient. The pathologist identified the biopsies as either
normal or cancerous. Moreover, the pathologist marked the
layers of the oral tissue (lamina propria and basal-cell
layer) on the image of the biopsies. For each biopsy, one
transmission image and two fluorescence images were
acquired using the ERL-MHIS.
2.3 Morphology-Based Fractal Dimension Method
for Tissue Discrimination
Fractal dimension is a ratio that gives statistics of com-
plexity, comparing how much detail in a pattern changes
with the scale at which it is measured [20]. In this work, the
complexity of the border between the lamina propria and
the basal-cell layer is represented using the fractal
dimension of the tissue image. Fractal dimension can be
calculated by taking the limit of the quotient of the log
change in object size and the log change in measurement




where D denotes the fractal dimension, s denotes the length
of the chosen smallest unit, and N denotes the number of
s required to cover the pattern. In this work, the nuclear
size with nine pixels is used as the smallest unit. N is the
image size (1000 9 1000 pixels). The fractal dimension is
calculated using the binary image version of the trans-
mission image.
The raw data of the transmission image must be cali-
brated before the fractal dimension is calculated. In this
work, the dark noise of the system is removed using a dark
image with no illumination. The nonuniformity of the
transmission image is then removed using a reference
blank, for which an area on the slide is scanned with all
layers of glass besides the cell structures. The nonunifor-
mity is caused by uneven illumination, scan line stripping,
effect of the lamp, and reflectance or transmittance of glass.
The calibration formula is:
TðkÞ ¼ ITðkÞ  IdarkðkÞ
IwhiteðkÞ  IdarkðkÞ ; ð2Þ
where T(k) denotes the calculated transmittance value of
each pixel in the transmission image, IT(k) denotes the
spectral intensity of raw data for each pixel in the trans-
mission image, Idark(k) denotes the spectral intensity of
each pixel in the dark field, and Iwhite(k) denotes the
spectral intensity of each pixel in the bright field.
Additionally, an attempt was made to acquire a binary
image with a clear border between the basal-cell layer and
the lamina propria by superimposing the transmission
image in the wavelength range of 500–700 nm. The largest
difference of spectral intensity between the basal-cell layer
and the lamina propria is in the wavelength range. Finally,
the fractal dimension of the binary image is calculated
using Eq. (1).
2.4 Five Spectrum-Based Methods for Cell
Discrimination
When the oral dysplasia arises from the epithelial tissue,
the number of nuclei in the basal-cell layer increases and
the nuclear shape and size change [3, 4]. Moreover,
according to previous studies [13–15], the nuclear spec-
trum presents a quantitative difference between normal,
precancerous, and cancerous cells. Therefore, it is
hypothesized that normal and cancerous cells differ in the
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nuclear spectrum of the basal-cell layer of epithelial tissue.
In this work, the analyzed spectral data are obtained from
two fluorescence images (obtained with F1 and F2 exci-
tation, respectively). We choose the nuclei with well dyed
and exclude the nuclei of border. Before analysis, the dark
noise must be removed. The calibration formula is
F(k) = IF(k)–Idark(k), where F(k) denotes the fluorescent
emission intensity of each pixel in the fluorescence image,
IF(k) denotes the spectral intensity of raw data of each
pixel in the fluorescence image, and Idark(k) denotes the
spectral intensity of each pixel in the dark field. After the
noise is removed, all of the nuclei in the basal-cell layer are
chosen. Each nucleus comprises nine pixels. For each
nucleus, the fluorescent emission spectral intensity is the
average spectral intensity of the nine pixels.
According to the characteristics of the emission spectral
shape, normal and cancerous cells were distinguished using
five methods (three methods for spectrum obtained with F1
excitation and two methods for spectrum obtained with F2
excitation). The emission spectral shape for F1 excitation
has two peaks and one valley (Fig. 3a); peak 1 at 560 nm,
peak 2 at 705 nm, and valley at 630 nm). Since the normal
cell and cancerous cell had different peak ratios or different
valley values, the first method uses the peak ratio (PR),
peak 1/peak 2, as a characteristic of spectral shape. The
second method uses the peak and valley ratio (PVR), with
the spectrum normalized by the intensity of peak 1. Then,
the formula (peak1 9 peak2)/valley is used as a charac-
teristic value of spectral shape. The third method uses the
area under the spectral curve (AUS1) normalized by the
intensity of peak 1 as a characteristic of spectral shape. The
emission spectral shape for F2 excitation has only one peak
(Fig. 3b); peak at 560 nm). The fourth method uses the
area under the spectral curve (AUS2) normalized by the
intensity of peak as a characteristic of spectral shape. The
fifth method uses the full width at half maximum (FWHM)
of the spectral curve as a characteristic of spectral shape.
Each cell can obtain one characteristic value from each
method. For each patient (two biopsies) and each method,
the characteristic values of normal cells and cancerous cells
were plotted as two distribution groups. The cut-off point
and optimal performance (sensitivity and specificity) of
each method were determined using the receiver operating
characteristic (ROC) curve [23]. Sensitivity and specificity
measure the inherent validity of a diagnostic method for
dichotomous results [24, 25]. Details on how to calculate of
sensitivity and specificity can be found elsewhere [25].
Sensitivity measures the proportion of actual positives that
are correctly identified as positive, that is, the percentage of
cancerous cells that are correctly identified. Specificity
measures the proportion of negatives that are correctly
identified, that is, the percentage of normal cells correctly
identified. However, specificity and sensitivity rely on the
cut-off point utilized to define ‘‘positive’’ and ‘‘negative’’
test results. Notably, sensitivity and specificity shift when
the cut-off point shifts. The ROC curve delineates the
trade-off between the sensitivity and (1-specificity) across
a series of cut-off points [24].
2.5 Spectrum-Based Cocktail Approach for Cell
Discrimination
This section describes how the cocktail approach deter-
mines which spectral methods are effective for each
patient. Previous works [15, 21, 22] have established that
the lesion site, tumor size, age, and lymph node metastasis
affected the cell spectrum. Therefore, in this work, patient
data were sorted according to the age, lesion site, size or
direct extent of the primary tumor (T), and degree of spread
to regional lymph nodes (N). Here, a method with a mean
sensitivity and a mean specificity of higher than 80 % was
defined as effective with respect to a specific condition. For
example, the ages of three patients (patients 18, 25, and 28)
ranged from 30 to 39 years old. The mean sensitivity and
mean specificity of the PR method for the three patients
were 76.8 and 73.46 %, respectively (Table 2). Hence, the
PR method is infeasible for patients in this age range. In
contrast, the mean sensitivity and mean specificity of the
PVR method were 91.43 and 83.6 %, respectively, for
these patients, and thus the method was considered effec-
tive. Once the most effective methods were determined for
each condition, their combination was used to diagnose a
biopsy, depending on its conditions. The cell must undergo
screening of all of the effective methods of the sample,
followed by its diagnosis as a normal or cancerous cell.
Figure 4 (in the Sect. 3.2) shows the flowchart that
describes how the cocktail approach finds the effective
methods for each condition.
2.6 Combined Diagnosis Based on Fractal
Dimension and the Cocktail Approach
The fractal dimension was first used to determine whether
the biopsy tissue was normal or abnormal. The cocktail
approach can further determine whether the cells were
normal or cancerous. The biopsy was thus determined as
normal or cancerous.
3 Results and Discussion
3.1 Morphological Identification Between Normal
and Abnormal Tissues
Table 1 shows information on the biopsies. Figure 2 dis-
plays the biopsy image of patient 7. Pathologists can obtain
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more information about the biopsy (e.g., the differentiation
and the stage) from the transmission images (Fig. 2a, e).
In this work, the complexity of the border between the
basal-cell layer and the lamina propria was represented
using the fractal dimension (Fig. 2a). Normal tissues had a
clear border between the basal-cell layer and the lamina
propria. In abnormal tissues, the cells eroded other cells,
leading to a disordered border [4]. Figures 2d and
2(h) show the binary images. The white area of the binary
image represents the border. Although the white area in the
normal tissue is a continuous curve, the white area in the
abnormal tissue is made up of discontinuous curves and
spread over the entire image. Therefore, in the binary
image, the border of abnormal tissue was more complex
than that normal tissue. When the binary image contained a
large number of white areas, the fractal dimension of the
binary image was high. Hence, the fractal dimension of
abnormal tissue was higher than that of normal tissue.
Table 1 Patient information
Group Patient no. Age Site T N Stage Number of nuclei
Normal Cancer
Training 1 71 Tongue 2 2 IV 555 478
2 50 Tongue 2 2 IV 158 156
3 41 Mucosa 1 0 I 260 164
4 42 Gum 2 2 IV 250 200
5 44 Gum 1 0 I 102 200
6 52 Gum 4 2 IV 166 160
7 64 Tongue 1 0 I 360 400
8 67 Mucosa 3 0 III 200 179
9 51 Pyriform sinus 4 2 IV 133 578
10 56 Gum 2 0 II 333 299
11 47 Pyriform sinus 3 2 III 255 399
12 51 Tongue 2 0 II 209 108
13 56 Mucosa 3 0 III 300 367
14 63 Palate 2 0 II 432 333
15 50 Tongue 2 2 IV 589 601
16 57 Gum 4 2 IV 200 309
17 52 Tongue 2 0 II 378 678
18 37 Tongue 1 2 IV 409 561
19 78 Tongue 2 0 II 444 500
20 60 Tongue 2 2 IV 400 266
21 80 Tongue 1 0 I 289 260
22 52 Palate 2 0 II 178 256
23 65 Mucosa 2 0 II 300 457
24 60 Tongue 3 0 III 398 457
25 34 Tongue 1 0 I 405 302
26 43 Tongue 2 2 IV 298 390
27 61 Palate 4 0 IV 203 599
28 32 Mucosa 1 0 I 592 212
29 56 Mucosa 1 0 I 402 700
Testing 30 65 Mucosa 2 0 N/A 214 692
31 41 Tongue 1 0 N/A 299 401
32 31 Mucosa 1 0 N/A 272 459
33 48 Tongue 2 3 N/A 393 598
34 37 Mucosa 2 0 N/A 505 496
The number of nuclei are those in the basal-cell layer
T Tthe size or direct extent of the primary tumor, T1, T2, T3, and T4 The size and/or extension of the
primary tumor, N The degree of spread to regional lymph nodes, N0 The tumor cells are absent from
regional lymph nodes, N1 The regional lymph node metastasis is present, N2 The tumor has spread to an
extent between N1 and N3, N3 The tumor has spread to more distant or numerous regional lymph nodes
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Closely examining column 1 of Table 2 reveals that the
criterion of fractal dimension for discrimination between
normal and abnormal tissues is 1.73; below this value, the
tissue was diagnosed as normal; otherwise, the tissue was
diagnosed as abnormal. Notably, the chosen nuclei were
well dyed and circle. Besides, when the objective power
was altered, the fractal dimension changed. The change of
fractal dimension was relative to the border complexity of
magnified tissue. Moreover, the fractal dimension was high
when the binary image of magnified tissue included a
significant number of white areas.
3.2 Spectral Identification Between Normal
and Cancerous Cells
Since the ERL-MHIS provides the fluorescence spectrum
of cell nuclei from the fluorescence images (Fig. 2b, c, f,
and g), this work attempted to determine whether there was
any spectrum-based difference between normal and
cancerous cells in the basal-cell layer. Previous works [11–
13] have established that the nuclear spectra at normal,
precancerous, and cancerous stages are different. Hence, in
this work, the nuclear spectrum was used to represent the
spectrum of each cell. Figure 3 displays the typical cell
spectra of various cancer stages, as obtained by the ERL-
MHIS. Under F1 excitation (330–385 nm), the shape of the
fluorescent emission spectrum had two peaks and one
valley. Peak 1 was located at 560 nm and peak 2 was
located at 705 nm. The valley was located at 630 nm.
When the peak 1 intensity was normalized, the peak 2
intensity showed a difference between stages. Furthermore,
the peak 2/peak 1 intensity ratio of normal cells was lower
than that of cancerous cells. This finding is consistent with
that of Roblyer et al. [26]. The peak 2 difference between
normal and cancerous cells was due to the difference in
porphyrin concentrations [27, 28]. Ramanujam et al.
attributed the valley difference to cell metabolism. Under
F2 excitation (470–490 nm), the fluorescent emission
spectrum had only one peak, located at 560 nm. When the
peak was normalized, the stages differed in the FWHM of
the spectrum [27]. The difference can be used to monitor
the changes of FAD concentration [29].
In order to distinguish between normal and cancerous
cells in terms of spectral difference, the characteristics of
spectral shape were described using five methods: PR,
PVR, AUS1, AUS2, and FWHM. The performance of each
method was evaluated based on the ROC curve. The cut-off
point, sensitivity, and specificity were also determined
(Table 2). Notably, under F1 excitation, although the nor-
mal cells of each patient had similar fluorescent emission
shapes, the 29 patients differed in intensity of the two
peaks or the valley. Under F2 excitation, these patients
slightly differed in the FWHM of normal cells. The
cancerous cells exhibited the same phenomenon under both
excitations. Therefore, the diagnostic performances of the
five spectral methods were not ideal. The methods were
suitable for some patients, but not others. For example, the
PR method yielded good results for patient 3, but not for
Fig. 2 Biopsy image of patient 7. a Transmission image of normal tissue. Fluorescence images of normal tissue under (b) F1 and (c) F2
excitation. d Binary image of normal tissue for calculating fraction dimension. e Transmission image of cancerous tissue. Fluorescence images of
cancerous tissue under (f) F1 and (g) F2 excitation. h Binary image of cancerous tissue for calculating fraction dimension
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patient 9. Hence, the five methods all showed high standard
deviations.
To solve the difference of nuclear spectrum between
patients, this work classified the 29 sample data according
to lesion site, tumor size, age, and lymph node metastasis.
Then, based on the proposed cocktail approach, the effec-
tiveness of the spectral methods in correlating with the
sampling conditions was determined. Figure 4 shows how
the cocktail approach determines the most effective
methods for each sampling condition. Table 3 lists the
most effective methods for each sampling condition. These
methods can be combined according to the sampling con-
ditions to diagnose a sample. For example, the combination
of methods AUS1 and FWHM was used to diagnose
sample 1 (71 years old, lesion on tongue, T2, and N2).
Before a cell is diagnosed using the most effective
method, the optimal cut-off point of the method must be
determined. The optimal cut-off point was defined as the
mean of total cut-off points under a specific condition. For
example, for patients 18, 25, and 28 (age: 30–39 years),
PVR was the most effective method. The optimal cut-off
point for PVR under this condition was the mean of the
three patients’ PVR cut-off points (1.55, 1.23, and 1.23, in
Table 2). Moreover, each effective method had different
optimal cut-off points under different conditions, because
each condition had a different patient group. For example,
the patient groups of T1 and T2 were different. Therefore,
the optimal cut-off points of AUS1 differed for T1 and T2.
3.3 Combined Diagnosis
The morphological changes of tissue were diagnosed using
the fractal dimension. Although this method can diagnose
the abnormal tissue, the abnormal tissue did not represent
cancerous tissue. It may represent hyperplasia. In hyper-
plasia tissue, the number of cells increases and the border
between the basal-cell layer and lamina propria becomes
disordered [4]. Hence, in this work, the fractal dimension
of hyperplasia tissue differed from that of normal tissue.
Moreover, whether the cells were cancerous or normal was
further confirmed using the cocktail approach.
Figure 5 compares the performances of all methods.
Because each method was appropriate for only some
patients, the standard deviation of each method was large.
In contrast, the cocktail approach showed a high mean
specificity, high mean sensitivity, and small standard
deviation, implying its better correlation with sample data.
In addition, the fourteen patients with early stage oral
carcinoma were successfully diagnosed with a sensitivity
of 90 ± 4.65 % and a specificity of 87.2 ± 5.06 %.




Fig. 3 Difference of mean
fluorescent emission spectrum
of cells between normal and
various oral cancer stages on
tongue (patients 7, 12, 24, and
26). Mean fluorescence
emission spectra of normal cells
and cancer cells under (a) F1
and (b) F2 excitation
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123
Moreover, 10 test samples were utilized to validate the
training results (Table 3). Note that the type of sample
(normal or cancerous) for the 10 test samples was not
revealed to the analyst during their analysis of the samples.
The 10 test samples were diagnosed according to the
patient’s conditions. The sensitivity and specificity of the
10 test samples were 80.16 ± 4.5 % and 81.74 ± 2.26 %,
respectively. Notably, the testing nuclei were chosen from
well dyed cells and cells away border. The results can be
enhanced by the correct patient’s condition. The concen-
tration and the time of the H&E would be the key
conditions.
In clinical application, the proposed approach can help
pathologist quantitatively diagnose biopsies. The procedure
of sample preparation and examination is the same as that
for pathological examination in a clinic. The procedure of
the diagnostic approach is controlled using programming.
Therefore, the approach is convenient for pathologists. In
addition, this is the first time that the ERL-MHIS was
utilized to diagnose oral carcinoma biopsy. This study also
provides a categorical approach of cellular spectrum to
enhance diagnosis performance for clinical oral carcinoma
research. The cut-off point of each method can be used as
reference data by researchers. Moreover, this study proves
that the spectrum of oral carcinoma cell relates to not only
the cancer stage but also the patient’s conditions.
4 Conclusion
This work developed morphological and spectral methods
and then combined them to help pathologists diagnose oral
carcinoma biopsy quantitatively. 68 biopsies of 34 oral
carcinoma patients were diagnosed based on the ERL-
MHIS. This is the first work to apply the ERL-MHIS to the
cytopathological examination of oral carcinoma. The
fractal dimension algorithm is applied to discriminate
between normal and abnormal tissues in terms of mor-
phological differences. For the spectral discrimination,
normal and cancerous cells are distinguished using five
methods. The spectra of normal and cancerous cells vary
with patient. The diagnostic results of the five methods are
thus not ideal. Therefore, the proposed cocktail approach is
utilized to determine the effectiveness of spectral methods
Fig. 5 Comparison of
performance of all methods.
(a) Mean sensitivity and
(b) mean specificity of 29
patients for each method
Table 3 Correlation between effective methods and patient’s conditions
Age 30–39 40–49 50–59 60–69 70–80




AUS1 (233) FWHM (66.3) AUS1 (236),
FWHM (60.7)
Site Tongue Mucosa Gum Palate Pyriform sinus
Method AUS1 (242.6) PVR (1.45) AUS1 (219.2), AUS2 (139.6) PVR (1.41) AUS2 (126)
T T1 T2 T3 T4
Method PVR (1.36), AUS1 (233.1) AUS1 (247.5) PVR (1.54), FWHM (66.3) AUS2 (139.5)
N N0 N2
Method PVR (1.46) AUS1 (246.5)
Number in parentheses is optimal cut-off point of each effect method under different condition
T The size or direct extent of the primary tumor, T1, T2, T3, and T4 The size and/or extension of the primary tumor, N The degree of spread to
regional lymph nodes. N0 The tumor cells absent from regional lymph nodes, N1 The regional lymph node metastasis present, N2 The tumor
spreads to an extent between N1 and N3, N3 The tumor spreads to more distant or numerous regional lymph nodes
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in correlating with the patient’s conditions. A combination
of effective spectral methods that depends on the patient’s
conditions is then used for diagnosing a biopsy. In addition
to promoting the mean sensitivity and mean specificity, the
proposed cocktail approach reduces the standard deviation.
Moreover, this study successfully diagnosed oral carci-
noma in its early stage. In the future, the k-nearest neighbor
method or principle component analysis method will be
used for finding characteristic molecules of different car-
cinoma stages. Furthermore, light-emitting diodes can be
used as the light source of the ERL-MHIS to reduce
scanning time.
Acknowledgments This paper was supported by the Aim for the
Top University Program of National Chiao Tung University, the
Ministry of Education of Taiwan (contract no. HCH102-39) and the
National Science Council of Taiwan (Grants NSC 101-2220-E-009-
032 and NSC 101-2218-E-039-001). The authors would like to thank
Mr. Chih-Hsien Chen, M.D. Ming-Hsui Tsai of China Medical
University Hospital, Professor Jin-Chern Chiou of National Chiao
Tung University, and Professor Jeng-Ren Duann of China Medical
University for providing experimental assistance and related
information.
Open Access This article is distributed under the terms of the
Creative Commons Attribution 4.0 International License (http://crea
tivecommons.org/licenses/by/4.0/), which permits unrestricted use,
distribution, and reproduction in any medium, provided you give
appropriate credit to the original author(s) and the source, provide a
link to the Creative Commons license, and indicate if changes were
made.
References
1. Jemal, A., Siegel, R., Xu, J., & Ward, E. (2010). Cancer statistics,
2010. CA: A Cancer Journal for Clinicians, 60, 277–300.
2. American Cancer Society: Cancer Facts & Figures, 2012. http://
www.cancer.org/acs/groups/content/@epidemiologysurveilance/
documents/document/acspc-031941.pdf
3. Patton, L. L., Epstein, J. B., & Kerr, A. R. (2008). Adjunctive
techniques for oral cancer examination and leison diagnosis-
asystematic review of the literature. Journal of the American
Dental Association, 139, 896–905.
4. Poh, C. F., Ng, S., Berean, K. W., Williams, P. M., Rosin, M. P.,
& Zhang, L. (2008). Biopsy and histopathologic diagnosis of oral
premalignant and malignant lesions. Journal/Canadian Dental
Association. Journal de l’Association Dentaire Canadienne, 74,
283–288.
5. Schultz, R., Nielsen, T., Zavaleta, J., Ruch, R., Wyatt, R., &
Garner, H. (2001). Hyperspectral imaging: a novel approach for
microscopic analysis. Cytometry, 43, 239–247.
6. Martin, M. E., Wabuyele, M. B., Chen, K., Kasili, P., Panjehpour,
M., Phan, M., et al. (2006). Development of an advanced
hyperspectral imaging (HSI) system with applications for cancer
detection. Annals of Biomedical Engineering, 34, 1061–1068.
7. Akbari, H., Uto, K., Kosugi, Y., Kojima, K., & Tanaka, N.
(2011). Cancer detection using infrared hyperspectral imaging.
Cancer Science, 102, 852–857.
8. Akbari, H., Halig, L. V., Schuster, D. M., Osunkoya, A., Master,
V., Nieh, P. T., et al. (2012). Hyperspectral imaging and quan-
titative analysis for prostate cancer detection. Journal of Bio-
medial Optics, 17, 07600501–07600510.
9. Fei, B., Akbari, H., & Halig, L. V. (2012). Hyperspectral imaging
and spectral-spatial classification for cancer detection. Proceed-
ing of the IEEE International Conference Biomedical Engineer-
ing & Informatics, 1, 62–64.
10. Kiyotoki, S., Nishikawa, J., Okamoto, T., Hamabe, K., Saito, M.,
Goto, A., et al. (2013). New method for detection of gastric
cancer by hyperspectral imaging: a pilot study. Journal of Bio-
medial Optics, 18, 0260101–0260106.
11. Dicker, D. T., Lerner, J., Belle, P. V., Barth, S. F., Guerry, D.,
Herlyn, M., et al. (2006). Differentiation of normal skin and
melanoma using high resolution hyperspectral imaging. Cancer
Biology & Therapy, 5, 1033–1038.
12. Dicker, D. T., Lerner, J. M., & El-Deiry, W. S. (2007). Hyper-
spectral image analysis of live cells in various cell cycle stages.
Cell Cycle, 6, 2563–2570.
13. Siddiqi, A. M., Li, H., Faruque, F., Williams, W., Lai, K.,
Hughson, M., et al. (2008). Use of hyperspectral imaging to
distinguish normal, precancerous, and cancerous cells. Cancer,
114, 13–21.
14. Li, Q., Liu, H., Wang, Y., Zhu, J., & Chang, L. (2012). Micro-
scopic hyperspectral imaging system used in rat skin analysis.
Proceeding of the IEEE Conference Biomedical Engineering &
Informatics, 1, 76–79.
15. Akbari, H., Halig, L. V., Zhang, H., Wang, D., Chen, Z. G., &
Fei, B. (2012). Detection of cancer metastasis using a novel
macroscopic hyperspectral method. Proceeding of the SPIE,
8317, 111–117.
16. Sun, C. W., Lee, S. Y., & Lin, K. F. (2014). Review: Optical
scanning probe for optical coherence tomography. Journal of
Medical and Biological Engineering, 34, 95–100.
17. Hsieh, Y. F., Ou-Yang, M., & Lee, C. C. (2011). Finite conjugate
embedded relay lens hyperspectral imaging system. Applied
Optics, 50, 6198–6205.
18. Hsieh, Y. F., Ou-Yang, M., Duann, J. R., Chiou, J. C., Chang, N.
W., Jan, C. I., et al. (2012). Development of a novel embedded
relay lens microscopic hyperspectral imaging system for cancer
diagnosis: use of the mice with oral cancer to be the example.
International Journal of Spectroscopy, 1–13, 2012.
19. Chang, N. W., Tsai, M. H., Lin, C., Hsu, H. T., Chu, P. Y., Yeh,
C. M., et al. (1812). Fenofibrate exhibits a high potential to
suppress the formation of squamous cell carcinoma in an oral-
specific 4-nitroquinoline 1-oxide/arecoline mouse model.
Biochimica et Biophysica Acta, 558–564, 2011.
20. Kenneth, F. (2003). Fractal geometry: Mathematical foundations
and applications. New York: Wiley.
21. Muller, M. G., Valdez, T. A., Georgakoudi, I., Backman, V.,
Fuentes, C., Kabani, S., et al. (2003). Spectroscopic detection and
evaluation of morphologic and biochemical changes in early
human oral carcinoma. Cancer, 97, 1681–1692.
22. de Veld, D. C., Skurichina, M., Witjes, M. J., Duin, R. P.,
Sterenborg, D. J., Star, W. M., & Roodenburg, J. L. (2003).
Autofluorescence characteristics of healthy oral mucosa at dif-
ferent anatomical sites. Lasers in Surgery and Medicine, 32,
367–376.
23. Metz, C. E. (1978). Basic principles of ROC analysis. Seminars
in Nuclear Medicine, 8, 283–298.
24. Kumar, R., & Indrayan, A. (2011). Receiver operating charac-
teristic (ROC) curve for medical researchers. Indian Pediatrics,
48, 277–287.
25. Altman, D. G., & Bland, J. M. (1994). Statistics notes: diagnostic
tests 1: Sensitivity and specificity. British Medical Journal, 308,
1552.
26. Roblyer, D., Kurachi, C., Stepanek, V., Williams, M. D., EI-
Naggar, A. K., Lee, J. J., et al. (2009). Objective detection and
delineation of oral neoplasia using autofluorescence imagin.
Cancer Prevention Research, 2, 423–431.
446 M. Ou-Yang et al.
123
27. Ramanujam, N. (2000). Fluorescence spectroscopy of neoplastic
and non-neoplastic tissues. Neoplasia, 2, 89–117.
28. Chaturvedi, P., Majumder, S. K., Krishna, H., Muttagi, S., &
Gupta, P. K. (2010). Fluorescence spectroscopy for noninvasive
early diagnosis of oral mucosal malignant and potentially
malignant lesions. Journal of Cancer Research and Therapeutics,
6, 497–502.
29. Pavlova, I., Williams, M., EI-Naggar, A., Richards-Kortum, R.,
& Gillenwater, A. (2008). Understanding the biological basis of
autofluorescence imaging for oral cancer detection: high-resolu-
tion fluorescence microscopy in viable tissue. Clinical Cancer
Research, 14, 2396–2404.
Biopsy Diagnosis of Oral Carcinoma by the Combination of Morphological and Spectral Methods… 447
123
